Sanofi

News and Events

Press Releases


April 29, 2026
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi

April 24, 2026
Press Release: Sanofi successfully prices 2.3 billion of bond issue

April 24, 2026
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses

Upcoming Events

30Jul

2026

Second Quarter 2026

Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.

Quarterly results


30Oct

2026

Third Quarter 2026

Third quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation will be followed by a Q&A session.

Quarterly results


Past Events

23Apr

2026

First quarter 2026

Q1 2026 results were reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation was followed by a Q&A session.

13:00 - 14:00 CET (7:00am - 8:00am EST)

Quarterly results

Discover more

29Jan

2026

Fourth Quarter & Full Year 2025 Results

Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation was followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EDT)

Quarterly results

Discover more

24Oct

2025

Third Quarter 2025

Third quarter 2025 results were reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation was followed by a Q&A session.

Quarterly results

Discover more